글로벌 관절통 약물 시장 – 2029년까지의 산업 동향 및 예측

시장 분석 및 규모

연골, 뼈, 인대, 힘줄, 근육을 포함한 관절의 모든 부분은 불편함, 통증 또는 염증을 일으킬 수 있습니다. 관절통은 신체의 하나 이상의 관절에 통증이 있는 것을 나타내는 용어입니다. 관절통은 관절염 및 기타 질병, 부상, 감염, 약물이나 음식에 대한 알레르기 반응을 포함한 다양한 원인으로 인해 발생할 수 있습니다. 관절 염증은 일반적으로 스테로이드 주사로 치료합니다. 관절 흡인은 필요한 경우 영향을 받는 관절에서 체액을 제거하는 치료법입니다(관절 천자술). 뼈가 부러져서 생긴 관절통은 수술이나 캐스트 사용이 필요할 수 있습니다.

Data Bridge Market Research는 관절통 약물 시장이 2021년에 645억 6천만 달러 규모였으며 2029년까지 890억 4천만 달러에 도달할 것으로 예상하고 2022년부터 2029년까지의 예측 기간 동안 4.10%의 CAGR을 기록할 것으로 분석했습니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

보고 범위 및 시장 세분화

Market Definition

Arthralgia is a painful condition that affects one or more joints. Sharp, dull, stabbing, scorching, or throbbing pain might occur, and its intensity can range from mild to severe. Arthralgia can be caused by a variety of factors, including injury, infection, arthritis, and other illnesses. Arthritis, or inflammation of the joints, is the most prevalent cause. Joint pain is the most common symptom of arthralgia. Joint pain can strike suddenly or gradually intensify over time.

Arthralgia Drugs Market Dynamics

Drivers

• Rise in the incidences of obesity

The surging incidences of obesity is a major factor driving the arthralgia drugs market's growth rate. Obesity puts extra strain on the knees and hips, causing the cushion joints to wear down more quickly. According to a factsheet published by the World Health Organization (WHO) in February 2018, 1.9 billion persons over 18 were overweight in 2016, with 650 million of them being obese. Obesity is considered a major risk factor causing arthralgia and hence, influencing the market dynamics during the forecast period of 2022-2029.

• Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of arthralgia drugs market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.

• Growing number of geriatric population

The surging geriatric population is estimated to enhance the market's expansion during the forecast period of 2022-2029. According to a factsheet published by the Centers for Disease Control and Prevention (CDC), between 2013 and 2015, 29.3 percent of people aged 45 to 64 and 49.6 percent of people aged 65 and up were diagnosed with arthritis in the United States. Geriatrics are more susceptible to get joint pain and further estimated to enhance the market's growth rate.

 Furthermore, rising initiatives by public and private organizations to spread awareness and rising healthcare expenditure will expand the arthralgia drugs market. Additionally, sedentary lifestyle of people and increasing number of cases of rheumatoid arthritis will result in the expansion of arthralgia drugs market.

Opportunities

• Increase in the number of research and development activities       

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the arthralgia drugs market growth. Along with this, rising drug approvals and launches will further propel the market's growth rate.

Moreover, rising investment for the development of advanced technologies and an increase in the number of emerging markets will provide beneficial opportunities for the arthralgia drugs market growth during the forecast period.

Restraints/Challenges

On the other hand, the expiration of patented drugs and the introduction of generic version of drugs will obstruct the market's growth rate. The lack of healthcare infrastructure in developing economies and high cost associated with drugs will challenge the arthralgia drugs market. Additionally, side effects linked with arthralgia drugs will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This arthralgia drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the arthralgia drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Arthralgia drugs market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Arthralgia Drugs Market

The COVID-19 outbreak and subsequent lockdown in numerous countries around the world had an impact on the financial status of enterprises in all sectors. The private healthcare sector is one of the areas where the pandemic had a significant impact. The pandemic's lockdown has put a financial strain on the private healthcare industry in a number of countries. Outpatient visits, manpower, equipment, consumables, and other resources were reduced. Furthermore, the coronavirus pandemic had a significant influence on medicine development, production, supply, and the businesses of different healthcare corporations around the world. The outbreak has resulted in the shutdown of industrial establishments, with the exception of those that manufacture critical commodities, and disruptions in product supply chains. As a result, the COVID-19 outbreak had impacted the economy in three ways: directly influencing production and demand, causing distribution channel disruptions, and having a financial impact on firms and financial markets. However, now that COVID-19 vaccines are readily available, numerous authorities are trying to assure that life-saving medications and vaccines are supplied without interruption. Hence, the arthralgia drugs market is projected to stabilize in the future.

Global Arthralgia Drugs Market Scope

The arthralgia drugs market is segmented on the basis of drug type, dosage form, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drug Type

• Non-steroidal anti-inflammatory (NSAID)
• Corticosteroids
• Antidepressants
• Narcotics
• Anticonvulsants
• Antibiotics
• Others

Dosage Form

• Injection
• Tablets
• Cream
• Others

Route of Administration

• Topical
• Parenteral
• Oral
• Others

End-Users

• Hospitals
• Specialty Clinics
• Homecare
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Arthralgia Drugs Market Regional Analysis/Insights

The arthralgia drugs market is analyzed and market size insights and trends are provided by country, drug type, dosage form, route of administration, end-users and distribution channel as referenced above.

The countries covered in the arthralgia drugs market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

북미는 시장 점유율과 시장 수익 측면에서 관절통 약물 시장을 지배하고 있으며 예측 기간 동안 지배력을 계속 확대할 것입니다. 이는 주요 핵심 기업의 존재와 증가하는 의료비 지출로 인해 이 지역의 시장 성장률이 더욱 높아질 것입니다.

아시아 태평양 지역은 이 지역의 비만 유병률 급증과 노령 인구 증가로 인해 2022년에서 2029년 사이의 예측 기간 동안 성장할 것으로 예상됩니다. 또한, 의료 인프라의 개발은 이 지역의 시장 성장률을 더욱 촉진할 것입니다.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 트렌드 및 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향은 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.   

경쟁 환경 및 관절통 약물 시장 점유율 분석

관절통 약물 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 위에 제공된 데이터 포인트는 관절통 약물 시장과 관련된 회사의 초점에만 관련이 있습니다.

관절통 약물 시장에서 활동하는 주요 업체는 다음과 같습니다.

• 파이저 주식회사(미국)
• GlaxoSmithKline plc (영국)
• 노바티스 AG(스위스)
• 마일런 NV(미국)
• Teva Pharmaceutical Industries Ltd. (이스라엘)
• 사노피(프랑스)
• 베링거 인겔하임 인터내셔널 GmbH. (독일)
• 아스트라제네카(영국)
• 존슨앤존슨 프라이빗 리미티드(미국)
• 머크앤코(미국)
• F. 호프만-라 로슈 유한회사(스위스)
• 브리스톨-마이어스 스퀴브 회사(미국)
• 엘리 릴리 앤드 컴퍼니(미국)
• 알러간(아일랜드)
• 애벗(미국)
• LEO Pharma A/S(덴마크)
• Sun Pharmaceutical Industries Ltd. (인도)
• Aurobindo Pharma(인도)
• 루팡(인도)
• 히크마 제약(영국)
• Amneal Pharmaceuticals LLC. (미국)
• 지두스 카딜라(인도)

SKU-56621